Piperidin-3-yl tetrahydro-2H-pyran-4-carboxylate hydrochloride

Catalog No.: 
ACZUWE365
CAS No.: 
1220020-84-7
Molecular Formula: 
C11H20ClNO3
Molecular Weight: 
249.74
Piperidin-3-yl tetrahydro-2H-pyran-4-carboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$143.00InquiryInquiry
5g95%$430.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePiperidin-3-yl tetrahydro-2H-pyran-4-carboxylate hydrochloride
IUPAC Namepiperidin-3-yl tetrahydro-2H-pyran-4-carboxylate hydrochloride
MDL No.MFCD13559741
Molecular FormulaC11H20ClNO3
Molecular Weight249.74
SMILESO=C(C1CCOCC1)OC2CNCCC2.[H]Cl
InChI KeyPYKAFXUKGXGOOJ-UHFFFAOYSA-N
Synonym3-Piperidinyl tetrahydro-2H-pyran-4-carboxylatehydrochloride;PIPERIDIN-3-YL TETRAHYDRO-2H-PYRAN-4-CARBOXYLATE HYDROCHLORIDE
CAS No.1220020-84-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZUWE365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGPEI042 route compound structure diagram
    ACGPEI04240191-32-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZUWE365 route product structure diagram
    ACZUWE3651220020-84-7
Inquiry

2. ACZUWE365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZUWE365 route product structure diagram
    ACZUWE3651220020-84-7
Inquiry

3. ACZUWE365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZUWE365 route product structure diagram
    ACZUWE3651220020-84-7
Inquiry

Comments (0)